期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Lipidomics in non-alcoholic fatty liver disease 被引量:6
1
作者 Sofia Kartsoli christina e kostara +2 位作者 Vasilis Tsimihodimos eleni T Bairaktari Dimitrios K Christodoulou 《World Journal of Hepatology》 CAS 2020年第8期436-450,共15页
Non-alcoholic fatty liver disease(NAFLD),the most common chronic liver disorder in Western countries,comprises steatosis to nonalcoholic steatohepatitis(NASH),with the latter having the potential to progress to cirrho... Non-alcoholic fatty liver disease(NAFLD),the most common chronic liver disorder in Western countries,comprises steatosis to nonalcoholic steatohepatitis(NASH),with the latter having the potential to progress to cirrhosis.The transition from isolated steatosis to NASH is still poorly understood,but lipidomics approach revealed that the hepatic lipidome is extensively altered in the setting of steatosis and steatohepatitis and these alterations correlate with disease progression.Recent data suggest that both quantity and quality of the accumulated lipids are involved in pathogenesis of NAFLD.Changes in glycerophospholipid,sphingolipid,and fatty acid composition have been described in both liver biopsies and plasma of patients with NAFLD,implicating that specific lipid species are involved in oxidative stress,inflammation,and cell death.In this article,we summarize the findings of main human lipidomics studies in NAFLD and delineate the currently available information on the pathogenetic role of each lipid class in lipotoxicity and disease progression. 展开更多
关键词 LIPIDOMICS Non-alcoholic fatty liver disease Non-alcoholic steatohepatitis LIPOTOXICITY Fatty acids CERAMIDES
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部